NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD
Acorda Therapeutics, Inc. (ACOR) has a consensus analyst rating of Hold, based on 19 analysts covering the stock. Of those, 5 recommend buying, 11 recommend holding, and 3 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
